
|Videos|June 6, 2017
Maintenance Pembrolizumab Did Not Improve PFS in Small-Cell Lung Cancer
Author(s)Shirish M. Gadgeel, MD
This video examines a phase II trial that studied maintenance pembrolizumab in extensive-stage small-cell lung cancer.
Advertisement
In this video, Shirish M. Gadgeel, MD, of the University of Michigan, discusses a phase II trial that studied pembrolizumab in the maintenance setting for the treatment of extensive-stage small-cell lung cancer patients.
Gadgeel presented results of the study (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma
2
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
3
Reducing Secondary Diagnostic Delay Through the Breast Clinical Reporting and Data System
4
Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC
5



































